(PFE) Pfizer Stock Price Forecast: 2025, 2026, 2027–2030 and Beyond

Pfizer (#PFE) stocks have garnered considerable attention from investors thanks to their promising upside potential and highly active market conditions. Amid global economic volatility and new healthcare challenges, #PFE offers a compelling option for both short- and long-term investments.

Forecasts for the coming years show a wide range of potential prices, reflecting possible fluctuations and yield increases. Analyzing current trends and seasonal movements presents a unique opportunity to identify optimal market entry points and assess investment risk. 

This article provides an in-depth analysis of Pfizer stocks, helping you grasp the intricacies of the market and empowering you to make more informed trading decisions.

The article covers the following subjects:

Major Takeaways

• The PFE stock price is trading at $25.69 as of 13.03.2025.
• The PFE price reached its all-time high of $61.25 on 2021-12-16. The stock’s all-time low of $0.43 was recorded on 1974-10-04.
• In 2024, the company implemented strategic initiatives to optimize its product lineup and expand its global footprint.
• The PFE stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol #PFE, making it accessible to a wide range of investors.
• The company maintains stable operating profit by actively investing in research and innovation.
• Free cash flow makes it possible to finance new projects and maintain proper dividend policy.
• Forecasts for 2025 indicate that revenue will continue to surge, and the global market position will strengthen.

Pfizer (PFE) Real-Time Market Status

The current Pfizer (#PFE) stock price is $25.69 as of 13.03.2025.

Investors should monitor key metrics that help assess the financial strength of a company, upside potential, and stock liquidity. For example, market capitalization indicates the overall value of the company, while trading volume reflects market activity. The P/E ratio assesses stock profitability, and the price change over the last 12 months helps to assess the stock performance. Additionally, dividend yield and maximum supply help gauge shares’ profitability and availability.

Metric	Value
Market cap	$149.79 billion
Trading volume over the last 24 hours	51.5 billion shares
P/E ratio	18.54
All-time high	$61.71
Price change over the last 12 months	-2.36%
Dividend yield	6.51%

Pfizer (PFE) Stock Price Forecast for 2025 Based on Technical Analysis

Let’s examine the #PFE stock daily chart to assess its short-term prospects for the next 3–6 months. The chart indicates that Pfizer securities are trading in a narrow range, with support levels at 25.90 and 24.80–25.00, where the price previously reversed. Resistance is positioned at 27.00–28.00.

The price is trading at 26.29, near the 50-period SMA, suggesting weak bullish momentum. The 200-period SMA at 27.80 serves as a long-term resistance level. The RSI stands at 53.18 and remains in the neutral zone, while the MACD lines are nearing a bullish crossover (0.0792 vs. 0.0202), indicating a possible upside move. A breakout above 27.80 is needed to confirm further gains, while a drop below 26.00 may trigger a correction toward 25.00.

Let’s look at the weekly #PFE chart to make a long-term forecast for the rest of 2025. Support is at 24.00–26.00, while resistance is at 30.00–31.00. The SMA9 and SMA21 indicate a possible trend change, although the price remains below the long-term resistance.

The RSI value of 46.53 confirms fading bullish momentum. Meanwhile, the MACD line (0.0744) is above the signal line (-0.5357), suggesting a potential move into the positive zone. However, the trend lacks clear momentum at this stage.

Fibonacci retracement analysis shows that the price has reached the key 38.2% level (near 26.50). The asset should consolidate above 28.00 to climb further to 35.00–37.00 (2023 highs).

Below are the Pfizer (#PFE) share price estimates for the remainder of 2025:

Month	Pfizer (#PFE) Shares Projected Values
Minimum, $	Maximum, $
March	25.9	28
April	26.2	28.5
May	26.8	29.5
June	27.5	30.5
July	28.5	32
August	29.5	33.5
September	30.5	35
October	31.5	36.5
November	32.5	38
December	33.5	40

Long-Term Trading Plan for PFE for 2025

Based on the technical analysis performed, the following trading plan for the PFE stock in 2025 can be made:

• Consider initiating long trades at 28.50 when the price breaks through the resistance of 28.00, supported by the RSI rising above 60 and the MACD bullish crossover.
• When the price hits the 30.00 level, one may secure a part of the profit and hold the trade open until the 35–37 level is reached.
• An alternative scenario suggests opening a trade on a rebound from the support of 26.00. A stop-loss order should be set below 25.50.
• If the asset breaches the support level and falls below 25.50, close the trade and consider a short-term sell.

Monitor trading volume and volatility to confirm signals. Additionally, you can use Fibonacci retracement levels. Besides, watch the moving averages since their convergence or divergence can warn about a trend reversal.

Analysts’ (PFE) Shares Price Projections for 2025

Some analysts believe 2025 may become a milestone year for the PFE stock. The projected range of $15.16–$43.70 indicates high volatility, offering opportunities for profitable short-term trading.

StockScan

Price range in 2025: $15.16–$27.04 (as of 3.03.2025).

StockScan predicts a decrease in #PFE quotes, with a low of $15.16 expected in April and a high of $27.04 in September. The forecast indicates a gradual price recovery with occasional fluctuations throughout the year.

Month	Minimum, $	Average, $	Maximum, $
April	15.16	20.06	23.54
May	18.84	23.70	24.26
June	24.00	25.19	26.59
July	20.21	20.91	25.88
August	19.11	21.38	22.51
September	22.08	26.07	27.04
October	23.56	24.05	26.70
November	23.11	24.43	25.25
December	22.42	23.31	26.66

Coin Price Forecast

Price range in 2025: $26.65–$26.97 (as of 3.03.2025).

According to Coin Price Forecast, #PFE quotes are projected to advance steadily in 2025. The price will likely reach $26.65 by mid-year and $26.97 by December.

Year	Mid-Year, $	Year-End, $
2025	26.65	26.97

CoinCodex

Price range in 2025: $26.43–$43.70 (as of 3.03.2025).

According to CoinCodex, Pfizer’s share price will soar substantially in 2025. The potential ROI (return on investment) will increase dramatically, making #PFE more appealing to long-term investors. The price is expected to reach its lowest value of $26.43 in March and the highest one of $43.70 in December.

Month	Minimum, $	Average, $	Maximum, $
March	26.43	27.42	28.13
April	27.88	28.98	30.19
May	29.78	30.45	30.86
June	28.71	29.94	30.94
July	29.18	30.20	31.82
August	32.25	35.34	38.14
September	32.48	33.48	34.32
October	31.72	32.48	33.12
November	33.21	36.33	39.22
December	37.60	40.74	43.70

Analysts’ Pfizer (PFE) Shares Price Projections for 2026

According to most analysts, the #PFE price will remain highly volatile in 2026. Let’s review some of the expert forecasts in more detail.

StockScan

Price range in 2026: $21.46–$40.37 (as of 3.03.2025).

StockScan predicts that the #PFE price will exhibit significant swings in 2026. Experts note that the asset will reach its lowest value in the first half of the year and rise to $40.37 in the last months.

Year	Minimum, $	Average, $	Maximum, $
2026	21.46	27.59	40.37

CoinCodex

Price range in 2026: $32.20–$42.94 (as of 3.03.2025).

According to CoinCodex, Pfizer’s share price will slide moderately in 2026. The asset is projected to hit a high of $42.94 in January and a low of $32.20 in October.

Year	Minimum, $	Average, $	Maximum, $
2026	32.20	35.57	42.94

Coin Price Forecast

Price range in 2026: $28.13–$29.13 (as of 3.03.2025).

Coin Price Forecast points to moderate appreciation. According to analysts, the #PFE price will trade at $28.13 in mid-2026 and will climb to $29.13 by year-end.

Year	Mid-Year, $	Year-End, $
2026	28.13	29.13

Analysts’ Pfizer (PFE) Shares Price Projections for 2027

Many analysis agencies are convinced that the #PFE stock will remain highly volatile in 2027. 

StockScan

Price range in 2027: $29.60–$50.54 (as of 3.03.2025).

StockScan provides a wide price range for Pfizer shares in 2027. Experts believe that sharp spikes in certain months indicate high volatility, presenting both opportunities and risks for investors.

Year	Minimum, $	Average, $	Maximum, $
2027	29.60	40.07	50.54

CoinCodex

Price range in 2027: $21.03–$38.73 (as of 3.03.2025).

CoinCodex offers various scenarios for the #PFE price performance in 2027. The predicted range of $21.03–$38.73 means that the stock can both plummet and skyrocket, providing investors with important benchmarks for evaluating potential ROI.

Year	Minimum, $	Average, $	Maximum, $
2027	21.03	28.03	38.73

Coin Price Forecast

Price range in 2027: $33.07–$33.80 (as of 3.03.2025).

The Coin Price Forecast indicates only slight increases ahead. The #PFE price is expected to stay within a narrow range, reflecting the market’s stability throughout the year.

Year	Mid-Year, $	Year-End, $
2027	33.07	33.80

Analysts’ Pfizer (PFE) Shares Price Projections for 2028

Forecasts for 2028 point to the volatility of #PFE quotes, capturing the impact of market trends and seasonal fluctuations. Experts anticipate both occasional hikes and corrections, providing investors with rough guidelines for future trading strategies.

StockScan

Price range in 2028: $25.96–$44.65 (as of 3.03.2025).

StockScan‘s forecast indicates a wide range of Pfizer share prices with noticeable fluctuations during the year. The asset is expected to reach the lowest price of $25.96 in December and the highest value of $44.65 in May.

Year	Minimum, $	Average, $	Maximum, $
2028	25.96	35.31	44.65

CoinCodex

Price range in 2028: $19.95–$24.21 (as of 3.03.2025).

CoinCodex predicts that the #PFE will appreciate moderately within a narrow range. The lowest price is expected to reach $19.95, while the highest price may hit $24.21. If the uptrend remains steady, the potential ROI may increase significantly.

Year	Minimum, $	Average, $	Maximum, $
2028	19.95	22.08	24.21

Coin Price Forecast

Price range in 2028: $35.09–$36.08 (as of 3.03.2025).

Coin Price Forecast predicts moderate upward movement for #PFE shares, with average values rising steadily from $35.09 mid-year to $36.08 by year-end, indicating gradual growth without sharp jumps.

Year	Mid-Year, $	Year-End, $
2028	35.09	36.08

Analysts’ Pfizer (PFE) Shares Price Projections for 2029

In 2029, analysts predict significant changes in #PFE quotes trajectory, reflecting both short-term fluctuations and sustained trends.

StockScan

Price range in 2029: $12.93–$28.06 (as of 3.03.2025).

StockScan offers a wide price range and predicts sharp swings in different months. The asset is expected to hit the highest value in January and the lowest price in December, indicating a potential downtrend.

Year	Minimum, $	Average, $	Maximum, $
2029	12.93	20.05	28.06

CoinCodex

Price range in 2029: $38.74–$39.22 (as of 3.03.2025).

According to CoinCodex, the #PFE price will trade in a narrow range, indicating relative stability. The price is expected to strengthen gradually, showing a moderate positive trend.

Year	Mid-Year, $	Year-End, $
2029	38.74	39.22

Coin Price Forecast

Price range in 2029: $19.06–$32.71 (as of 3.03.2025).

Coin Price Forecast presents a range of scenarios showcasing various price levels throughout the year. Thus, Pfizer shares are expected to undergo moderate dips as well as notable gains.

Year	Minimum, $	Average, $	Maximum, $
2029	19.06	25.89	32.71

Analysts’ Pfizer (PFE) Shares Price Projections for 2030

2030 is set to bring significant shifts in #PFE quotes, showing significant plunges and short-term upticks. Forecasts point to high volatility, creating both opportunities and risks for investors.

StockScan

Price range in 2030: $2.43–$17.83 (as of 3.03.2025).

StockScan predicts a steep slump and significant fluctuations in Pfizer shares, with peaks observed in February and troughs in December. This suggests high volatility and considerable market risks.

Year	Minimum, $	Average, $	Maximum, $
2030	2.43	10.13	17.83

CoinCodex

Price range in 2030: $23.62–$32.11 (as of 3.03.2025).

CoinCodex‘s prediction underscores the volatility of Pfizer’s stock in 2030, with noticeable month-to-month fluctuations. These variations indicate that investors may experience both gains and periods of moderate losses throughout the year.

Year	Minimum, $	Average, $	Maximum, $
2030	23.62	27.87	32.11

Coin Price Forecast

Price range in 2030: $42.56–$43.44 (as of 3.03.2025).

Coin Price Forecast projects that the #PFE price will soar significantly within a stable trend. The potential increase from mid to late 2030 emphasizes positive expectations and consistent market momentum.

Year	Mid-Year, $	Year-End, $
2030	42.56	43.44

Analysts’ Pfizer (PFE) Shares Price Projections until 2050

According to most forecasts, the Pfizer Inc. share price will tumble in the long term. Analysis agencies highlight increasing volatility in the coming decades, presenting both profit opportunities and heightened risks of loss for investors.

StockScan predicts that the #PFE stock price will fluctuate between $10.02 and $12.47 in 2035, averaging $11.62. By 2040, it is expected to plummet to $6.88–$8.55 and to $4.50–$5.30 by 2050. Experts attribute the price slump to a general decline in demand and changes in the macroeconomic environment.

Coin Price Forecast also suggests a gradual depreciation of the #PFE price. The asset is expected to trade at $7.72 in 2040 and at $4.77 in 2050, representing a 65%–80% decline from current levels

Experts at CoinCodex believe that despite the overall deterioration, the stock may preserve its value, which is reflected in the forecast. The asset’s highest price will likely reach $7.34 at the end of 2040 and $5.18 at the end of 2050.

Year	StockScan, $	Coin Price Forecast, $	CoinCodex, $
2035	12.47	—	—
2040	8.55	7.72	7.34
2050	5.30	4.77	5.18

Most forecasts for 2035–2050 indicate a strong downward movement for the #PFE price. However, estimates for such an extended period are approximate, as it is impossible to predict all the events that may affect the share price. Therefore, it is crucial to thoroughly analyze relevant information regarding the asset before making trading decisions.

Market Sentiment for Pfizer (PFE) on Social Media

Media sentiment analysis involves assessing posts and comments on social networks, news headlines, etc. It allows you to understand how potential investors feel about a particular financial asset.

Social media sentiment often influences the market situation. Positive media sentiment, usually triggered by the release of successful financial reports or new developments, drives the price up. In contrast, negative media sentiment associated with business problems or doubts about a company’s strategy can spark a sell-off and a decrease in share price.

Monitoring media sentiment helps promptly adjust investment strategies, reducing risks and enhancing the efficiency of trading decisions. Additionally, this data allows traders and investors to predict trends and take measures to protect capital.

@jartz, a user of the X social network (formerly Twitter), notes that the #PFE chart looks “healthier.” The user believes the price can break through the key resistance level (“neckline”) and establish a sustained uptrend.

User @pnani456 describes the #PFE chart as a “defensive play.” Judging by the chart, the user emphasizes the stock’s relatively consistent behavior amid market volatility and hints that Pfizer shares may become a reliable option for long-term investors who prioritize dividends and capital protection.

Based on these examples, the overall sentiment regarding #PFE remains positive. Investors perceive the stock as a reliable asset that can offer consistent income even in times of high volatility.

Pfizer (PFE) Price History

Pfizer reached the highest price of $61.25 on 2021-12-16. The lowest price of Pfizer was recorded on 1974-10-04 when the stock declined to $0.43.

The chart below shows the #PFE price performance over the last ten years. It is crucial to evaluate historical data to make our forecasts as accurate as possible.

Pfizer’s share price has hit several key milestones since the early 2000s:

• In 2000, the #PFE price hit a record high of about $50, bolstered by the successful launch of blockbuster drugs such as Viagra, Lipitor, and Zoloft.
• From 2004 to 2009, the #PFE price plunged to $12–$15 due to the company losing several patents and facing heightened competition. Moreover, the global financial crisis of 2008 contributed to these challenges.
• From 2013 to 2019, Pfizer’s share price stabilized in the $35–$45 range thanks to advances in oncology, vaccines, biopharmaceuticals, and a solid dividend policy.
• In 2021, the asset set an all-time high of $61 as sales of Comirnaty, a vaccine developed with BioNTech, generated record revenue for the company.
• In 2023–2025, demand for the vaccine dropped sharply, consequently reducing revenue, and the #PFE price plummeted.
• In Q1 2025, Pfizer shares traded around $26, reflecting the company’s response to ongoing challenges and ability to adapt to new market conditions.

The Pfizer stock has historically demonstrated the capacity to recover from severe downturns, indicating future upside potential.

Pfizer (PFE) Fundamental Analysis

Fundamental analysis plays a key role in forecasting the price of any asset. It involves assessing financial data, the company’s market position, and other indicators affecting the #PFE rate.

What Factors Affect the Pfizer (PFE) Stock?

• Financials. The company’s revenues, net income, profitability, and cash flows.
• Development and market launch of new drugs. Successful clinical tests and regulatory approvals.
• Patent protection. Expiration of patents on key drugs, the emergence of generics.
• Mergers and acquisitions. Strategic deals that expand product range and distribution markets.
• Regulatory environment. Changes in healthcare legislation and policy.
• Global economic conditions. Economic crises, currency fluctuations, and geopolitical instability.
• Competition. Actions of major competitors and innovation in the industry.
• Reputational risks. Lawsuits, fines, and public opinion.
• Dividend policy. Changes in the amount and regularity of payments to shareholders.
• Investor sentiment. General trends in the stock market and investors’ attitude to the pharmaceutical sector.

Given these factors, investors can objectively assess the prospects of the Pfizer stock and make more informed decisions.

More Facts About Pfizer (PFE)

Pfizer Inc. is a prominent American biopharmaceutical company founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York. The company develops, produces, and sells drugs and vaccines to treat various diseases. Pfizer is particularly well-known for its flagship products, such as Lipitor (atorvastatin) to lower cholesterol, Viagra (sildenafil) to address erectile dysfunction, and Prevenar, a pneumococcal vaccine.

In 2020, Pfizer, in collaboration with the German company BioNTech, developed Comirnaty, one of the first COVID-19 vaccines based on mRNA technology, which significantly boosted Pfizer’s global profile. The company is actively investing in research and development to expand its range of innovative medicines and solidify its position in the global pharmaceutical market.

Advantages and Disadvantages of Investing in Pfizer (PFE)

Pfizer is one of the largest pharmaceutical companies producing popular and effective medications. Moreover, it adheres to a solid dividend policy, which makes the #PFE stock a safe investment option. However, like any other asset, #PFE carries not only benefits but also risks.

Advantages

• Stable pharmaceutical business. Wide range of high-demand drugs and vaccines.
• Dividend payouts. The yield is above the market average (~5%).
• Innovation leadership. Significant investments in R&D and breakthrough drugs (oncology, vaccines).
• Defensive asset. Demand for drugs remains strong even during crises.
• Global expansion. Operations in key pharmaceutical markets.
• Government support. Cooperation with regulators and research funding.
• Access to new technologies. Regular acquisitions of biotech companies.

Disadvantages

• Declining post-COVID revenues. Falling demand for vaccines and drugs used for COVID-19 treatment.
• Dependence on regulators. FDA approvals and patent litigation can impact revenue.
• Risk of patent expiration. Loss of exclusive rights reduces revenues (Lipitor is an example).
• High competition. Competing with other pharma giants for market and innovation.
• Long development cycle. Clinical tests can take years and failures lead to significant losses.
• Sensitivity to macroeconomics. Drug price regulation, inflation.
• Stock fluctuations. Despite the stability of this field, the PFE price is susceptible to market trends.

Pfizer (PFE) is a resilient pharmaceutical company known for its solid dividends and opportunities for growth through innovation. However, investors should keep in mind that the stock price might be influenced by factors such as declining post-COVID earnings, upcoming patent expirations, and intense competition. Although the asset is suitable for long-term investments, it is essential to assess the associated risks thoroughly.

How We Make Forecasts

Stock prices are forecasted based on three time frames:

• Short-term forecasts (up to 6 months) rely on technical analysis (support/resistance levels, indicators, volumes) and news. Macroeconomic events, reports, and market reactions are taken into account.
• Medium-term forecasts (from 6 months to 3 years) include fundamental analysis (financial indicators, competitive advantages, sales trends). Macroeconomic trends, interest rates, geopolitics, and the company’s product cycle are assessed.
• Long-term forecasts (3 years or more) are focused on strategic analysis. Industry potential, innovation, growth prospects, capital management, and global factors are explored. Besides, discounted cash flow (DCF) models and multiple valuations are also used.

However, each new forecast requires adjustment to align with the latest data and evolving market conditions.

Conclusion: Is Pfizer (PFE) a Good Investment?

Pfizer stands as one of the largest pharmaceutical companies with strong financial performance, a diversified range of pharmaceutical products, and consistent dividend payouts. Despite falling revenues following the pandemic, the company continues to invest in research, which bolsters its long-term upside potential. Nonetheless, the stock is subject to risks associated with patent expirations, regulatory changes, and intense competition. 

Overall, PFE is a reliable option for long-term investors who prioritize dividends. However, it is crucial to monitor market conditions carefully and practice strategic risk management.

Pfizer Price Prediction FAQs

What is the current price of Pfizer Shares?

The current Pfizer (PFE) stock price is $25.69 as of 13.03.2025.

Will Pfizer’s stock rise?

Pfizer shares show promising upside potential, especially if the price breaks through the key resistance of $28.00. The company not only maintains a steady dividend payout but also continues to invest heavily in research and development. However, its expansion largely depends on regulatory decisions, demand for new drugs, and market conditions.

What is the future of the Pfizer stock price?

The future of Pfizer shares is uncertain, with forecasts suggesting a wide price range. If successful innovations occur, the pharmaceutical sector stabilizes, and macroeconomic conditions are favorable, the stock may climb to $35–$40. However, regulatory risks and competition may inhibit growth, reducing the value to $2–$8.

Is Pfizer a good investment in 2025?

In 2025, #PFE remains a solid asset due to its high dividend yield (6.51%) and strong fundamental indicators. However, the stock faces pressure because of lower post-COVID earnings and regulatory risks. Thus, investors should consider that the asset may surge above $28.00, yet risk analysis is required.

What will the Pfizer stock price be worth in 2026?

Predictions for the Pfizer stock in 2026 suggest a wide price range. StockScan estimates a range of $21.46–$40.37, Coin Price Forecast predicts an increase to $29.13, and CoinCodex expects a jump to $42.94. Ultimately, the price movement will depend on the company’s financial results and market environment.

What will Pfizer be worth in 2030?

Experts disagree on the #PFE price forecast in 2030. StockScan anticipates that the asset will trade in the range of $21.46–$40.37, Coin Price Forecast predicts a rise to $29.13, and CoinCodex forecasts a hike to $42.94.

What is the real value of the Pfizer stock?

The real value of the Pfizer stock is determined by a combination of fundamental factors and market conditions. Current market capitalization stands at $149.79 billion, the P/E ratio is 18.54, and the dividend yield is 6.51%. Intrinsic value hinges on future earnings, innovation, and regulatory risks.

Is Pfizer’s stock a good long-term investment?

The Pfizer stock can be a promising long-term investment thanks to its steady dividend payout (6.51%), strong pharmaceutical product lineup, and ongoing investment in research. However, declining earnings following the COVID-19 pandemic, upcoming patent expirations, and competition pose risks. Should the stock price surpass the $28.00 mark, it could signal upward momentum for the asset.

Price chart of PFE in real time mode

The content of this article reflects the author’s opinion and does not necessarily reflect the official position of LiteFinance broker. The material published on this page is provided for informational purposes only and should not be considered as the provision of investment advice for the purposes of Directive 2014/65/EU.

According to copyright law, this article is considered intellectual property, which includes a prohibition on copying and distributing it without consent.